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The endogenous opioid system has been reported to depress the cardiovascular system 
during shock states, since naloxone, a potent opiate antagonist, enhances recovery of 
hemodynamic variables in various shock states. However, the effect of naloxone on 
long-term survival of experimental animals exposed to hypovolemic hypotension is not 
clear. The present studies tested the capacity of various doses of naloxone to protect 
conscious rats from mortality following various bleeding paradigms. In addition, the 
effect of morphine on survival of rats exposed to hemorrhage was also examined. In 
the six different experimental protocols tested, naloxone treatments failed to improve 
short- or long-term survival; in fact, naloxone treatment reduced short-term survival 
in two of the experimental protocols. Morphine injection, however, enhanced the 
mortality of rats exposed to hemorrhage in a dose-dependent manner. It is concluded 
that while opiates administered exogenously decrease survival after acute bleeding, 
naloxone has no protective action in such states and, like morphine, it may decrease 
survival in some situations. 
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INTRODUCTION 
Opiates have been long known to affect the cardiovascular system [1,2]. The 
endogenous opioid system has also been implicated in cardiovascular regulation since 
a) opioid peptides and their receptors are found in cardiovascular nuclei in the central 
nervous system [3,4]; b) opioid peptides have pronounced effects on cardiorespiratory 
variables when administered centrally or peripherally [5-8]; c) stress responses that 
are accompanied by hemodynamic changes were shown to activate the endogenous 
opioid system as shown by analgesia and other behavioral changes [for review, see 
Ho}aday, 5]. 
Hemorrhage is another cardiovascular stress situation in which the endogenous 
opioid system has been stated to play a detrimental role since naloxone, a potent 
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opiate antagonist, was shown to enhance cardiovascular recovery [9-15]. However, 
although many studies have been able to demonstrate a pressor response to naloxone 
in hypovolemic hypotension, only a few studies examined the effect of naloxone 
treatment on short-term survival. An increase in survival of naloxone-treated con-
scious rats bled to a fIxed low blood pressure [9] or fIxed volume withdrawal [15] 
was shown in two studies. An increase in survival rate in naloxone-treated animals 
was also found in anesthetized dogs exposed to hypovolemic hypotension and treated 
with naloxone [12,13] or the partial opiate antagonist/agonist nalbuphine [16]. How-
ever, Travero et al [17] failed to demonstrate any benefIcial effect on short- or long-
term survival in a swine model of hemorrhagic shock in which similar treatments of 
naloxone were given. Also, Gurll et al [18] failed to demonstrate any signifIcant 
effect of naloxone on survival rate of the anesthetized cynomolgus monkeys exposed 
to hemorrhage. 
Since the ultimate goal of treatment is to provide a superior long-term outcome 
from the original insult, surviving a hemorrhagic event is the ultimate end result of 
treatment. Unfortunately, very few studies have examined the effect of naloxone on 
the survival of animals in addition to studing hemodynamic, biochemical, and neu-
roendocrine responses; in only two studies, increased survival of conscious animals 
was reported [9,15]. In one of the reports [9] only one hemorrhagic paradigm was 
studied while in the other [15] no benefIcial effect of naloxone was found in severe 
hemorrhage; moreover, in this later study [15] morphine also tended to increase 
survival of rats exposed to hemorrhage. 
In view of the overall limited information on the effect of naloxone on the 
survival rate of conscious animals following hypovolemic hypotension, and the 
present controversy on the potential therapeutic value of naloxone in this and other 
shock situations, we decided to study the effect of naloxone on survival of conscious 
rats exposed to hemorrhage. A fixed volume bleeding approach was selected for these 
studies since such a bleeding better represents the nature of profuse bleeding resulting 
from injuries to civilian or military personnel in combat situations. Although this 
mode of bleeding results in some variability in systemic hypotension at the end of the 
bleeding in some species, it is not the case in the conscious rat where mean arterial 
blood pressure consistently drops to 40-45 nunHg [19]. In order to produce graded 
survival curves, a second bleeding event was introduced to the protocol, which 
resulted in LD30-LDlOO' The doses of naloxone selected for this study as well as the 
treatment schedules are based on previous studies [5,9, 15, 17], In addition, the effect 
of morphine on the survival of conscious rats exposed to hemorrhage was also studied 
since no clear data exist on the survival of conscious rats after bleeding. 
MATERIALS AND METHODS 
Male Sprague Dawley rats (250-300g) were purchased from Taconic Farms 
(Germantown, NY) and kept at 22°c and 12 hr/12 hr light/dark cycle. Rats were 
anesthetized with pentobarbitone (40 mg/kg, Lp.) and polyethylene catheters (PE SO) 
were inserted into the femoral artery and vein through a small incision in the groin. 
The catheters were then threaded under the back skin and exteriorized at the back of 
the neck; thereafter, the catheters were secured by a spring wire and an adhesive 
collar loosely attached around the neck. This method is a modifIed technique previ-
ously described by Chiueh and Kopin [20] and slightly modified as previously 
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described in detail [6]. Rats were allowed to recover from surgery for 24-36 hr with 
food and tap water ad libitum. 
Hemorrhage was instituted by withdrawal of blood from the arterial line through 
a hand-driven syringe as described below for the various protocols. The shed blood 
was not replaced. Control animals received injections of normal (0.9%) saline at the 
same time points where naloxone was injected. A separate group of rats was always 
included with each different naloxone experiment. Naloxone (kindly provided by 
DuPont Pharmaceuticals, Wilmington, DE) was dissolved in 0.9% NaCI and injected 
as a bolus intravenously (0.2 ml), followed by 0.2 ml flush. The following experi-
mental protocols were used: 
1. Bleeding 9.5 ml/300 g body weight over a 5-min period; 5 min later, naloxone 
(10 mg/kg) was injected in a single bolus dose. Survival of rats was followed hourly 
up to 24 hr after the bleeding. This protocol represents a situation in which profuse 
bleeding over a short period of time results in only short-term survival for most of 
the animals. This model represents the clinical scenario of rapid but not immediately 
fatal hemorrhage. 
2. Bleeding 8.5 ml/300g over a 5-min period; naloxone (2 mg/kg) was injected 30 
min after the original bleeding. Ninety minutes after the fIrst hemorrhage, a second 
bleeding of 2 ml/300g was added; 60 min later, a second injection of naloxone (2 
mg/kg) was given. Survival rate was followed for 24 hr after the bleeding. 
3. The same bleeding protocol was used as in protocol number 2 except for a 3-ml/ 
300-g second bleeding and a third naloxone injection 120 min after the second one. 
4. The same protocol of bleeding and naloxone injections as described in protocol 
3 except 5 ml/300 g for the second bleeding. 
5. Bleeding 8.5 ml/300 g followed by 1.5 ml/300 g 90 min later; naloxone (5 mg/ 
kg) was injected 30 min after the first bleeding, followed by six consecutive 
injections of 2.5 mg/kg naloxone. Survival was monitored for 72 hr. 
6. Bleeding was conducted as described in protocol 3. Naloxone treatment was 
started 30 min after the first bleeding as a 2- or 5-mg/kg bolus followed by six 
consecutive injections of naloxone, 1 mg/kg in the group that received a bolus of 2 
mg/kg, and four consecutive additional injections in the group that received a 5-
mg/kg bolus. Survival of rats was followed for 24 hr. 
7. Bleeding was done as described in protocol number 2; morphine sulphate 
(dissolved in 0.9% NaCl) was administered 30 min after the first bleeding; two 
different doses of morphine (0.5 and 5 mg/kg) were tested in separate groups of 
rats. Control rats received an injection of 0.9% NaCI at the same time points of 
morphine injections to the treated group. 
In all the experimental protocols, control animals received the same volume of 
0.9% NaCl as naloxone-treated rats. Also, injections of saline or naloxone were done 
by a blinded procedure and survival of rats monitored by a technician unaware of the 
treatments. 
STATISTICS 
The Fisher exact probability test was used to compare differences in survival 
rate of naloxone- and salinewtreated rats. 
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RESULTS 
The different bleeding paradigms resulted in 35-100 % mortality of the control 
rats (Fig. 1-6). The highest volume loss (8.5 + 5 mg/300 g hemorrhage) had a 
LDlOO, while some variability existed in the mortality after the other bleeding sched-
ules. Therefore, it is important to note that in each study, a separate control group 
was always exposed to bleeding concomitantly with the corresponding drug treated 
group. 
The results of the various studies with naloxone are presented in Figures 1-5. 
In none of the experimental protocols did naloxone improve the survival rate of rats 
exposed to bleeding. 
In protocol 1 and 5, naloxone-treated rats showed enhanced mortality that 
reached statistical significance; in protocol 3, a tendency of enhanced mortality in 
naloxone-treated rats was also observed. 
In experiments in which a single dose of morphine was administered to rats 30 
min after the fIrst bleeding, the survival of rats was substantially reduced in a dose-
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Fig. 1. Effect of naloxone on survival rate of rats exposed to hemorrhage of 9.5 ml/300 g. Percent 
survival is indicated in the ordinate. Time (hours) is indicated in the abscissa. O. saline-treated 
hemorrhaged rats; ., naloxone-treated rats. Time of bleeding and volume is indicated as tH; time of 
naloxone treatment is given as tN. Asterisks denote statistical significance by Fisher exact probability 
test. Number of rats in each group is given in parentheses. 
Fig. 2. Effect of naloxone on survival of rats exposed to 8.5 ml/300 g hemorrhage followed by 2-ml 
(panel A) or 3 ml/300 g (panel B) bleeding. Percent survival is indicated in the ordinate. Time (hours) 
is indicated in the abscissa. 0, saline-treated hemorrhaged rats; ., naloxone-treated rats. Time of 
bl~i~g an? ~olume is indicated as tH; time of naloxone treatment is given as tN. Asterisks denote 
statistical Significance by Fisher exact probability test. Number of rats in each group is given in 
parentheses. 
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Fig. 3. Effect of naloxone on survival of rats exposed to 8.5 ml/300 g hemorrhage followed by 5 mll 
300 g bleeding. Percent survival is indicated in the ordinate. Time (hours) is indicated in the abscissa. 
0, saline-treated hemorrhaged ratsi • I naloxone-treated rats, Time of bleeding and volume is indicated 
as tH; time of naloxone treatment is given as iN. Asterisks denote statistical significance by Fisher 
exact probability test. Number of rats .in each group is given in parentheses. 
Fig. 4. Effect of naloxone on survival of rats exposed to 8.5 ml/300 g hemorrhage followed by 1.5 mll 
300 g bleeding. Percent survival is indicated in the ordinate. Time (hours) is indicnted in the abscissa. 
0, saline-treated he1l1orrhuged rats; ., nnloxone-treated ruts. Time of bleeding and volume is indicated 
as tHj time of naloxone treatment is given as tN. Asterisks denote statistical significance by Fisher 
exact probab1lity test. Number of rats in ench gl'OUp is given in parentheses. 
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Fig. 5. Effect of naloxone on survival of rats exposed to 8.5 ml hemorrhage followed by 3 ml/300 g 
bleeding. Percent survival is indicated in the ordinate. Time (hours) is indicated in the abscissa. 0, 
saline-treated hemorrhaged rats; ., naloxone-treated rats. Time of bleeding and volume is indicated as 
tH; time of naloxone treatment is given as tN. Asterisks denote statistical significance by Fisher exact 
probability test. Number of rats in each group is given in parentheses. 
Fig. 6. Effect of morphine on survival of rats exposed to 8.5 ml/300 g hemorrhage followed by 2 mll 
300 g bleeding. Percent survival is indicated in the ordinate. Time (hours) is indicated in the abscissa. 
Symbols of the different groups are depicted in the figure. Time of bleeding and volume is indicated as 
tH. Asterisks denote statistical significance by Fisher exact probability test. Number of rats in each 
group is given in parentheses. Injection of a single dose of morphine, 0.5 or 5.mg/kg, is denoted by 
t~o. . 
related manner (Fig. 6.). The low dose of morphine reduced survival from approxi-
mately 60 to 15 % while no survivors were found in the group of rats treated with the 
high dose of morphine (5 mg/kg). 
It is also pertinent to note that in all the experiments, rats surviving 24 hr 
completely recovered. 
DISCUSSION 
The results of the present studies clearly indicate that naloxone has no protective 
effect in rats exposed to fixed volume bleeding without reinfusion of the shed blood. 
In fact, enhanced mortality of naloxone-treated rats was found in two experiments 
(Figs. 1 and 4) while a tendency to reduce survival was seen in a third experiment 
(Fig. 2B). A decrease in average survival time after naloxone treatment was also 
reported in fixed volume bleeding in the swine [17]. The range of naloxone doses 
used in this study is in the same range used in several previous studies in which 
naloxone's effect on survival was studied [9,13,14,15]. The major difference of the 
present study from that by Faden and Holaday [9] is the mode of bleeding; in the 
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prese~t study, the hemorrhage was done by volume while in the latter study, bleeding 
was almed at producing a constant low blood pressure over a given period of time. 
However, the amount of shed blood reported in the latter study [9] was in the same 
range of the bleeding produced in the present study. Nevertheless, our data also vary 
from those by Isoyama et al [15], who used a volume-hemorrhage similar to that in 
the present study. However, even in the latter study [15] naloxone failed to improve 
survival rate in rats exposed to bleeding of an LDso and had a protective effect only 
in rats in which bleeding resulted in LD40• Although in the fIXed-volume hemorrhage, 
the state of shock is less apparent when monitored by systemic hemodynamic vari-
ables, it has the advantage of being more relevant to human situations, eg, combat 
injuries [21] and civilian accidents [22] in which death results within a few hours 
after the bleeding. 
Our study also shows that morphine administration to rats exposed to oligemia 
is definitely a detrimental pharmacological intervention. These results are different 
from a previous report [15] in which the same dose of morphine (0 .. 5 mg/kg) was 
administered to rats exposed to hemorrhage. Bleeding procedures and anesthesia are 
possible factors for the discrepancy between the two studies, which were conducted 
in the same species using similar doses of morphine. In the previous study [15), 
bleeding was done while the animals were still anesthetized with pentobarbitone; 
moreover, the bleeding was done over 60 seconds in which almost 40 % of the blood 
was shed. In our study, the bleeding was done over 5 min, which allowed a larger 
volume of bleeding both during the first and second hemorrhage to achieve compara-
ble mortality rates. In addition, the study by Isoyama et al [15] differs from that by 
Faden and Holaday [9] by the lack of a pressor response to naloxone in either the 
moderate (LD40) or severe (LDgo) hemorrhage experiments. 
Although the mechanisms involved in the morphine enhancement of mortality 
rate were not studied, it is reasonable to propose that respiratory depression leading 
to hypoxemia and acidosis might have played a major role. This suggestion is 
supported by the known effects of opiates (eg, morphine) and opioid peptides that are 
Wagonists [23,24]. Other mechanisms, such as reduced blood flow to essential 
organs, were also suggested [25]. In conclusion, the studies reported in this paper 
failed to support previous suggestions that naloxone exerts a protective effect in 
severe oligemia. However, our studies suggest that exogenous opiates like morphine 
have a detrimental effect on survival in hemorrhagic shock. 
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